Table 1 |
|
|
Antimicrobial Treatment for C. difficile-associated disease based on disease severity |
|
|
Disease classification |
Recommended treatment |
|
|
|
|
Mild to moderate disease (mild to moderate diarrhea, leukocytosis <15,000/μl) |
Metronidazole 500 mg orally 3 times/day for 10 to 14 days |
|
Severe disease (fever, profuse diarrhea, abdominal pain, leukocytosis ≥15,000/μl, elevated creatinine) |
Vancomycin 125 to 500 mg orally 4 times/day for 10 to 14 days |
|
Severe disease, complicated (hypotension, shock, toxic megacolon, ileus) |
Vancomycin 500 mg enterally by nasogastric tube and/or rectal enema 4 times/day with or without intravenous metronidazole 500 mg every 8 hours |
|
|
|
|
Adapted using data from [6,43,44,54,56,79,92]. |
|
|
Gould and McDonald Critical Care 2008 12:203 doi:10.1186/cc6207 |
|